Paediatric & Adolescent Gynaecology Fellowship Program the Paediatric
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Urology / Gynecology Business Unit (UGBU) Strategy
Urology / Gynecology Business Unit (UGBU) Strategy Minoru Okabe Head of Uro/Gyn Business Unit Olympus Corporation March 30, 2016 Todayʼs Agenda 1.Business Overview 2.Recognition of Current Conditions 3.Market Trends 4.Business Strategies 5.Targets and Indicators 2 2016/3/30 No data copy / No data transfer permitted Todayʼs Agenda 1.Business Overview 2.Recognition of Current Conditions 3.Market Trends 4.Business Strategies 5.Targets and Indicators 3 2016/3/30 No data copy / No data transfer permitted Positioning of UG Business within Olympus 4 2016/3/30 No data copy / No data transfer permitted Distribution of Sales and Positioning FY2016 Net Sales (Forecast) Urology / Gynecology Business Unit (UGBU)* ET 72.0 Surgical Flexible and rigid endoscopes Benign prostatic hypertrophy and bladder Medical Business Devices* GI (ureteroscopes and cystoscopes) tumor resectoscopes and therapeutic FY2016 Net Sales electrodes (disposable) 337.4 205.6 (Forecast) ¥615.0 billion Urology field Flexible hysteroscopes * The figure for Surgical Devices net sales (¥205.6 billion) includes Stone treatment Gynecology field net sales of the Urology / Gynecology Business Unit (UGBU). devices (disposable) Resectoscopes Colposcopes 5 2016/3/30 No data copy / No data transfer permitted Applications and Characteristics of Major Products Field Urology Flexible Ureteroscope Stone Treatment Therapeutic Flexible Cystoscope Resectoscope URF-V2 Devices Electrodes (Disposable) CYF-VH OES Pro. (Disposable) Product Flexible ureteroscopes are used for Flexible cystoscopes are Resectoscopes are used to treat treating urinary stones. used to treat bladder benign prostatic hypertrophy and Feature Olympus flexible ureteroscopes have a tumors. bladder tumors. dominating edge realized by merging GI Olympus flexible Bipolar TURis electrodes endoscope technologies with the small cystoscopes have a (disposable) boast higher levels of diameter scope technologies of former dominating edge realized cutting safety and performance company Gyrus. -
Nutrition in Andrology, Gynaecology and Obstetrics
Appendix No. 2 to the procedure of development and periodical review of syllabuses Nutrition in Andrology, Gynaecology and Obstetrics 1. Imprint Faculty name: English Division Syllabus (field of study, level and educational profile, form of studies, Medicine, 1st level studies, practical profile, full time e.g., Public Health, 1st level studies, practical profile, full time): Academic year: 2019/2020 Nutrition in Andrology, Gynaecology and Module/subject name: Obstetrics Subject code (from the Pensum system): Educational units: Department of Social Medicine and Public Health Head of the unit/s: Dr hab. n. med. Aneta Nitsch - Osuch Study year (the year during which the 1st-6th respective subject is taught): Study semester (the semester during which the respective subject is Winter and Summer semesters taught): Module/subject type (basic, corresponding to the field of study, Optional optional): Teachers (names and surnames and Anna Jagielska, MD degrees of all academic teachers of Aleksandra Kozłowska, BSc respective subjects): ERASMUS YES/NO (Is the subject available for students under the YES ERASMUS programme?): A person responsible for the syllabus (a person to which all comments to Anna Jagielska, MD the syllabus should be reported) Number of ECTS credits: 2 Page 1 of 4 Appendix No. 2 to the procedure of development and periodical review of syllabuses 2. Educational goals and aims The aim of the course is to provide students with: 1. The principles of nutrition during adolescence, adulthood and eldery. 2. The relationship between nutrition and fertility, fetal status and communicable diseases in the adults life. 3. Basics of dietary advices for men and women in the reproductive years. -
Guidelines for the Management of Sexually Transmitted Infections
GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS WHO Library Cataloguing-in-Publication Data World Health Organization. Guidelines for the management of sexually transmitted infections. 1.Sexually transmitted diseases - diagnosis 2.Sexually transmitted diseases - therapy 3.Anti-infective agents - therapeutic use 4.Practice guidelines I.Expert Consultation on Improving the Management of Sexually Transmitted Infections (2001 : Geneva, Switzerland) ISBN 92 4 154626 3 (NLM classifi cation: WC 142) © World Health Organization 2003 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specifi c companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. -
Sexually Transmitted Infections (STI)
WOMEN ANDKing NEWBORN Edward Memorial HEALTH SERVICE Hospital ObstetricsKing Edward & Gynaecology Memorial Hospital CLINICAL PRACTICE GUIDELINE Sexually Transmitted Infections (STI) This document should be read in conjunction with the Disclaimer Contents Screening tests for sexually transmitted infections .......................... 2 Specimen collection ................................................................................................ 2 Screening tests ........................................................................................................ 2 Equipment ............................................................................................................... 2 Summary table for screening tests1 ......................................................................... 3 Screening tests: Asymptomatic patients (male & female) ................ 5 Procedure: Routine screening ................................................................................. 5 Screening tests: Symptomatic female ................................................ 7 Procedure ................................................................................................................ 7 Screening tests: Symptomatic male ................................................... 9 Routine screening in symptomatic men ................................................................... 9 Interpretation of treponemal serology .............................................. 10 Cryotherapy ....................................................................................... -
Male Infertility Low Testosterone
Male Infertility low testosterone. One of the first academic medical centers in the Both are fellowship-trained, male reproductive urologists prepared to deal nation to create a sperm bank continues to lead with the most complex infertility cases and the way in male infertility research and in complex to perform complex microsurgeries, such as vasectomy reversals and testicular-sperm clinical care. extraction. Partnering with URMC’s female infertility experts, the male infertility clinic An andrology lab and sperm bank were bank, today URMC’s Urology department is part of a designated in-vitro fertilization created more than 30 years ago at the now boasts two fellowship-trained male center of excellence in New York state. University of Rochester Medical Center infertility specialists—Jeanne H. O’Brien, (URMC). Grace M. Centola, Ph.D., M.D. and J. Scott Gabrielsen, M.D., Ph.D. Complex Care H.C.L.D., former associate professor of A nationally recognized male-infertility URMC’s male infertility clinicians see a Obstetrics and Gynecology at URMC, expert, O’Brien has received numerous growing number of patients with male- was instrumental in creating the bank, in awards and recognitions for both her factor infertility, such as decreased collaboration with Robert Davis, M.D., clinical and basic science research work. sperm counts, motility or morphology. and Abraham Cockett, M.D., from the Gabrielsen focuses on male reproductive The first steps in the care process are a Department of Urology. health, including male infertility, erectile baseline semen analysis, coupled with Building on the groundbreaking sperm dysfunction, male sexual dysfunction and an understanding of a patient’s health 4 UR Medicine | Department of Urology | urology.urmc.edu history. -
Galen and the Widow: Towards a History of Therapeutic Masturbation in Ancient Gynaecology
Open Research Online The Open University’s repository of research publications and other research outputs Galen and the widow: towards a history of therapeutic masturbation in ancient gynaecology Journal Item How to cite: King, Helen (2011). Galen and the widow: towards a history of therapeutic masturbation in ancient gynaecology. EuGeStA: Journal on Gender Studies in Antiquity, 1 pp. 205–235. For guidance on citations see FAQs. c 2011 EuGeStA Version: Proof Link(s) to article on publisher’s website: http://eugesta.recherche.univ-lille3.fr/revue/pdf/2011/King.pdf Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies page. oro.open.ac.uk Galen and the widow. Towards a history of therapeutic masturbation in ancient gynaecology* Helen King The Open University, UK [email protected] In a book published in 1999, The Technology of Orgasm, Rachel Maines argued that therapeutic masturbation had a very long history even before technological change enabled the development of the object at the centre of her research, the vibrator. She states that “Massage to orgasm of female patients was a staple of medical practice among some (but certainly not all) Western physicians from the time of Hippocrates until the 1920s, and mechanizing this task significantly increased the number of patients a doctor could treat in a working day”1. The purpose of this paper is to assess her claim of continuity by examining the place of desire, orgasm and masturbation in the Greco-Roman world and, to a much lesser extent, the Middle Ages and Renaissance2. -
Post-Orgasmic Illness Syndrome: a Closer Look
Indonesian Andrology and Biomedical Journal Vol. 1 No. 2 December 2020 Post-orgasmic Illness Syndrome: A Closer Look William1,2, Cennikon Pakpahan2,3, Raditya Ibrahim2 1 Department of Medical Biology, Faculty of Medicine and Health Sciences, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia 2 Andrology Specialist Program, Department of Medical Biology, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo Hospital, Surabaya, Indonesia 3 Ferina Hospital – Center for Reproductive Medicine, Surabaya, Indonesia Received date: Sep 19, 2020; Revised date: Oct 6, 2020; Accepted date: Oct 7, 2020 ABSTRACT Background: Post-orgasmic illness syndrome (POIS) is a rare condition in which someone experiences flu- like symptoms, such as feverish, myalgia, fatigue, irritabilty and/or allergic manifestation after having an orgasm. POIS can occur either after intercourse or masturbation, starting seconds to hours after having an orgasm, and can be lasted to 2 - 7 days. The prevalence and incidence of POIS itself are not certainly known. Reviews: Waldinger and colleagues were the first to report cases of POIS and later in establishing the diagnosis, they proposed 5 preliminary diagnostic criteria, also known as Waldinger's Preliminary Diagnostic Criteria (WPDC). Symptoms can vary from somatic to psychological complaints. The mechanism underlying this disease are not clear. Immune modulated mechanism is one of the hypothesis that is widely believed to be the cause of this syndrome apart from opioid withdrawal and disordered cytokine or neuroendocrine responses. POIS treatment is also not standardized. Treatments includeintra lymphatic hyposensitization of autologous semen, non-steroid anti-inflamation drugs (NSAIDs), steroids such as Prednisone, antihistamines, benzodiazepines, hormones (hCG and Testosterone), alpha-blockers, and other adjuvant medications. -
Pediatric Urology in the 21St Century
Pediatric Urology in the 21st Century • Richard Caesar, MD • Urologic Surgeons of Maine General Pediatric Urology • Undescended Testis • Acute pediatric scrotum • Urinary Tract Infection • Vesico-ureteral reflux • Lower urinary tract dysfunction • Circumcision • Hypospadias/labial adhesions • Varicocele Terminology Undescended; abdominal, canal, and pre-scrotal (superficial inguinal ring) Retractile Testis; palpable in canal; during examination, testis stays in scrotum; observation ; normal histology Terminology Ascending Testis; can be manipulated in to scrotum but does not stay; abnormal histology Ectopic testis; testis distal to the external ring but not in the scrotum; femoral, perineal or contralateral scrotum Infertility/UDT • Paternity • Bilateral 65% • Unilateral 89% • Control 93% Lee et al; PSU UDT Incidence depends on birth weight and prematurity NB 3 months Premature 30 % 10% Term 3 % 1% Rarely does descent occur past 3 months Cancer Risk in UDT • % DX Testis Ca • USA- AA 0.3% • Scandinavian 0.7% • UDT 3-5% • Contralateral of UDT 1.5-2% • Hussmann et al Pedi Urol 2001 12 months - delay in germ cell development (Ad spermatogonia) 24 month; peri-tubular fibrosis 3-4 yrs/Adulthood; Germ cell aplasia with vacuolization AUA Guidelines Guidelines Guidelines Differential for Scrotal Pain • Testicular Torsion 16-31% • Torsion of Appendix Testis 31-46% • Epididymitis • Hernia • Hydrocele • Tumor • Trauma • Henoch-Schonlein Purpura • Idiopathic Scrotal Edema • Varicocele History Timing of Onset of Pain • Torsion; acute/unrelenting • App -
Masturbation – Between Normality and Pathology Vasile Nitescu
Journal of Clinical Sexology - Vol. 4; No.2: April- June 2021 75 MASTURBATION- BETWEEN NORMALITY AND PATHOLOGY (FROM THE INTRAUTERINE STAGE TO PUBERTY)-PART I 1*Vasile NIȚESCU 1.*Medical Centre for Obstetrics-Gynaecology and Sexology; Abstract Performing manual stimulating maneuvers on the genitals by an individual (at first - su- perficially, accommodating, then well determined), regardless of gender and age, in order to achieve a sexual erotic state, often completed by ejaculation and orgasm, defines the masturbation . During puberty, masturbation is not a perverse act, being determined neurohormonally, in the normal evolution of childhood to normal adulthood. At puberty, specific sex hormones increase the sensitivity and the excitation of the tactile receptors of the genitals and their adjacent areas, with erotic sensitivity such as those of the perineal floor, anal region and urethra. The occurance of an erection is essential for masturbation in both sexes. Masturbation is completed by obtaining orgasm, caused by nerve impulses that are transmitted through the spinal cord sympathetic nerves from T12-L2, after which the erection decreases, as well as the state of pleasure obtained. Keywords: eroticism, masturbation, spinal cord, erection, orgasm, brain. *Correspondence: 1*Assoc. Professor Nițescu Vasile, MD,PhD, E-mail [email protected], phone +40723151804 76 Journal of Clinical Sexology - Vol.4; No.2: April- June 2021 Introduction: Penis erection and the vulvar vasodilation are determined by the intensity of sexual sti- Masturbation achieves sexual relaxation mulation, by impulses of the parasympathetic of the young man, who is at a time of insuf- vegetative nervous system, nerve endings re- ficient neuropsychic and anatomical deve- leasing nitric oxide and/or vasoactive intesti- lopment, the age at which, normally, parents nal peptide (VIP) and acetylcholine (Guyton, and society do not agree to the premature be- Benson). -
Sexually Transmitted Infections Treatment Guidelines, 2021
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 70 / No. 4 July 23, 2021 Sexually Transmitted Infections Treatment Guidelines, 2021 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS Introduction ............................................................................................................1 Methods ....................................................................................................................1 Clinical Prevention Guidance ............................................................................2 STI Detection Among Special Populations ............................................... 11 HIV Infection ......................................................................................................... 24 Diseases Characterized by Genital, Anal, or Perianal Ulcers ............... 27 Syphilis ................................................................................................................... 39 Management of Persons Who Have a History of Penicillin Allergy .. 56 Diseases Characterized by Urethritis and Cervicitis ............................... 60 Chlamydial Infections ....................................................................................... 65 Gonococcal Infections ...................................................................................... 71 Mycoplasma genitalium .................................................................................... 80 Diseases Characterized -
Male Anorgasmia: from “No” to “Go!”
Male Anorgasmia: From “No” to “Go!” Alexander W. Pastuszak, MD, PhD Assistant Professor Center for Reproductive Medicine Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Disclosures • Endo – speaker, consultant, advisor • Boston Scientific / AMS – consultant • Woven Health – founder, CMO Objectives • Understand what delayed ejaculation (DE) and anorgasmia are • Review the anatomy and physiology relevant to these conditions • Review what is known about the causes of DE and anorgasmia • Discuss management of DE and anorgasmia Definitions Delayed Ejaculation (DE) / Anorgasmia • The persistent or recurrent delay, difficulty, or absence of orgasm after sufficient sexual stimulation that causes personal distress Intravaginal Ejaculatory Latency Time (IELT) • Normal (median) à 5.4 minutes (0.55-44.1 minutes) • DE à mean IELT + 2 SD = 25 minutes • Incidence à 2-11% • Depends in part on definition used J Sex Med. 2005; 2: 492. Int J Impot Res. 2012; 24: 131. Ejaculation • Separate event from erection! • Thus, can occur in the ABSENCE of erection! Periurethral muscle Sensory input - glans (S2-4) contraction Emission Vas deferens contraction Sympathetic input (T12-L1) SV, prostate contraction Bladder neck contraction Expulsion Bulbocavernosus / Somatic input (S1-3) spongiosus contraction Projectile ejaculation J Sex Med. 2011; 8 (Suppl 4): 310. Neurochemistry Sexual Response Areas of the Brain • Pons • Nucleus paragigantocellularis Neurochemicals • Norepinephrine, serotonin: • Inhibit libido, -
Sexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS CONTENTS (Continued) Introduction ............................................................................................................1 Gonococcal Infections ...................................................................................... 60 Methods ....................................................................................................................1 Diseases Characterized by Vaginal Discharge .......................................... 69 Clinical Prevention Guidance ............................................................................2 Bacterial Vaginosis .......................................................................................... 69 Special Populations ..............................................................................................9 Trichomoniasis ................................................................................................. 72 Emerging Issues .................................................................................................. 17 Vulvovaginal Candidiasis ............................................................................. 75 Hepatitis C ......................................................................................................... 17 Pelvic Inflammatory